Conrad Wai - 14 Dec 2025 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO, Counterpart Health
Signature: /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai
Issuer symbol: CLOV
Transactions as of: 14 Dec 2025
Net transactions value: -$265,710
Form type: 4
Filing time: 16 Dec 2025, 16:20:35 UTC
Previous filing: 04 Nov 2025
Next filing: 20 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wai Conrad	CEO, Counterpart Health	C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON	/s/ Peter J. Rivas as attorney-in-fact for Conrad Wai	16 Dec 2025	0001971702

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Tax liability	$265,710	-98,411	-8.6%	$2.70	1,051,674	14 Dec 2025	Direct	F1
holding	CLOV	Class A Common Stock						1,610,482	14 Dec 2025	By Trust.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.